These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26238868)

  • 1. Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?
    Senoh M; Kato H; Fukuda T; Niikawa A; Hori Y; Hagiya H; Ito Y; Miki H; Abe Y; Furuta K; Takeuchi H; Tajima H; Tominaga H; Satomura H; Kato H; Morita S; Tanada A; Hara T; Kawada M; Sato Y; Takahashi M; Higuchi A; Nakajima T; Wakamatsu Y; Toyokawa M; Ueda A; Roberts P; Miyajima F; Shibayama K
    J Med Microbiol; 2015 Oct; 64(10):1226-1236. PubMed ID: 26238868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
    Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
    Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
    Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
    Nicholas A; Kim YK; Lee WK; Selasi GN; Na SH; Kwon HI; Kim YJ; Lee HS; Song KE; Shin JH; Lee JC
    PLoS One; 2017; 12(3):e0174716. PubMed ID: 28355266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
    Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P
    J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a Clostridium difficile PCR ribotype 078 100 kilobase island reveals the presence of a novel transposon, Tn6164.
    Corver J; Bakker D; Brouwer MS; Harmanus C; Hensgens MP; Roberts AP; Lipman LJ; Kuijper EJ; van Leeuwen HC
    BMC Microbiol; 2012 Jul; 12():130. PubMed ID: 22747711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Polish outbreak of Clostridium difficile ribotype 027 infections among dialysis patients.
    Lachowicz D; Szulencka G; Obuch-Woszczatyński P; van Belkum A; Pituch H
    Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):63-67. PubMed ID: 25060801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
    Kato H; Senoh M; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102011. PubMed ID: 30872073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Epidemiology of a Protracted Hospital Outbreak Caused by a Toxin A-Negative Clostridium difficile Sublineage PCR Ribotype 017 Strain in London, England.
    Cairns MD; Preston MD; Lawley TD; Clark TG; Stabler RA; Wren BW
    J Clin Microbiol; 2015 Oct; 53(10):3141-7. PubMed ID: 26179308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.
    Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR ribotypes of
    Gonzales-Luna AJ; Carlson TJ; Dotson KM; Poblete K; Costa G; Miranda J; Lancaster C; Walk ST; Tupy S; Begum K; Alam MJ; Garey KW
    Emerg Microbes Infect; 2020; 9(1):341-347. PubMed ID: 32037964
    [No Abstract]   [Full Text] [Related]  

  • 15. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.
    Tickler IA; Goering RV; Whitmore JD; Lynn AN; Persing DH; Tenover FC;
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4214-8. PubMed ID: 24752264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain.
    Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A
    Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, toxin gene profile, genotypes and antibiotic susceptibility of
    Saber T; Hawash YA; Ismail KA; Khalifa AS; Alsharif KF; Alghamdi SA; Saber T; Eed EM
    Indian J Med Microbiol; 2020; 38(2):176-182. PubMed ID: 32883931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.
    Quesada-Gómez C; López-Ureña D; Acuña-Amador L; Villalobos-Zúñiga M; Du T; Freire R; Guzmán-Verri C; del Mar Gamboa-Coronado M; Lawley TD; Moreno E; Mulvey MR; de Castro Brito GA; Rodríguez-Cavallini E; Rodríguez C; Chaves-Olarte E
    J Clin Microbiol; 2015 Apr; 53(4):1216-26. PubMed ID: 25653402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial-resistant strains of Clostridium difficile from North America.
    Tenover FC; Tickler IA; Persing DH
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2929-32. PubMed ID: 22411613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of Clostridium difficile infection in a major chinese hospital: an underrecognized problem in Asia?
    Hawkey PM; Marriott C; Liu WE; Jian ZJ; Gao Q; Ling TK; Chow V; So E; Chan R; Hardy K; Xu L; Manzoor S
    J Clin Microbiol; 2013 Oct; 51(10):3308-13. PubMed ID: 23903542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.